Other compounds such as the flavonoids apigenin and luteolin, as well as the potent Nrf2 inhibitor chrysin, among others, have been shown to reduce the expression of Nrf2 and its target genes, which suggests that these compounds may be considered as potential anti-cancer agents [86]. This evidence concerns the gene NFE2L2 and cancer.